Article
MGMT and PTEN as potential prognostic markers in breast cancer.
Experimental and molecular pathology - 1 Feb 2012
Neto Julio Cirullo, Ikoma Mariana Mari, Carvalho Katia Cândido, Vassallo José, De Brot Marina, Gobbi Helenice, Soares Fernando Augusto, Rocha Rafael Malagoli
Abstract excerpt
AIM: To evaluate the prognostic importance of MGMT and PTEN concerning their correlation with other prognostic factors evaluated by immunohistochemistry (IHC) and the molecular phenotype of breast cancers. METHODS: IHC for estrogen and progesterone receptors, HER2, Ki67, p53, p63, e-cadherin, EGFR, CK5, CK14, MGMT and PTEN was performed on 200 breast tumors. Basal-like and luminal breast carcinomas were defined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
